June 8, 2015 4:14 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings per share.The trailing-twelve-month earnings per share at
Trinity Biotech plc (ADR) (NASDAQ: TRIB) is $1.22. Trinity Biotech's revenue for the same period is $105.10 million.The trailing-twelve-month earnings per share at
SurModics, Inc. (NASDAQ: SRDX) is $0.94. SurModics' operating margin for the same period is 33.60 percent.The trailing-twelve-month earnings per share at
Neogen Corporation (NASDAQ: NEOG) is $0.85. Neogen's ROE for the same period is 9.80 percent.The trailing-twelve-month earnings per share at
Meridian Bioscience, Inc. (NASDAQ: VIVO) is $0.83. Meridian Bioscience's PEG ratio is 1.39.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.